Results 211 to 220 of about 3,301,387 (267)

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

BURRELLE'S TV CLIPS.

open access: yes, 1988
BURRELLES TV CLIPS
core  

Topographic sketching for surgical planning after neoadjuvant chemotherapy in breast cancer: a non-invasive localization method. [PDF]

open access: yesLangenbecks Arch Surg
Muslumanoglu M   +10 more
europepmc   +1 more source

ADP‐ribosylation: An emerging regulator of the epigenome

open access: yesMolecular Oncology, EarlyView.
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho   +2 more
wiley   +1 more source

BURRELLE'S TV CLIPS.

open access: yes, 1987
BURRELLES TV CLIPS
core  

Point-of-care echocardiography screening for hypertrophic cardiomyopathy using automated deep-learning analysis. [PDF]

open access: yesEur Heart J Digit Health
Karra N   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy